Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.
Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, Grobbee DE, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Oparil S, Spiering W, Williams B, Wright JT Jr, Lakshman P, Uluwattage W, Hay P, Pereira T, Amarasena N, Ranasinghe G, Gianacas C, Shanthakumar M, Liu X, Wang N, Gnanenthiran SR, Whelton PK; GMRx2 Investigators.
Lancet. 2024 Oct 19;404(10462):1536-1546. doi: 10.1016/S0140-6736(24)01744-6.
PMID:39426836
Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study.
Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J.
Radiat Oncol. 2022 Dec 20;17(1):208. doi: 10.1186/s13014-022-02180-6.
PMID:36539787
Ultra-low-dose chest CT imaging of COVID-19 patients using a deep residual neural network.
Shiri I, Akhavanallaf A, Sanaat A, Salimi Y, Askari D, Mansouri Z, Shayesteh SP, Hasanian M, Rezaei-Kalantari K, Salahshour A, Sandoughdaran S, Abdollahi H, Arabi H, Zaidi H.
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index.
Ren M, Yu Q, Custodio MG, Simoncini T, Nappi RE, Tatarchuk T, Kahler E, Piha T, Stevenson JC.
Climacteric. 2025 Feb;28(1):21-27. doi: 10.1080/13697137.2024.2418497. Epub 2024 Oct 30.
PMID:39475406
Ultra-low dose rate brachytherapy (uLDR-BT) in treatment of patients with unfavorable intermediate-risk group prostate cancer - retrospective analysis.
Kluska A, Chyrek A, Burchardt WM, Włodarczyk M, Bielęda G, Chicheł A.